Exelon

NDC 0078-0502 · Novartis Pharmaceuticals Corporation

Generic namerivastigmine

Dosage formPATCH, EXTENDED RELEASE

RouteTRANSDERMAL

Active ingredient(s)RIVASTIGMINE

Strength9.5 mg/24h

Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]

Marketing categoryNDA

Packages

0078-0502-15 — 30 PATCH in 1 CARTON (0078-0502-15) / 24 h in 1 PATCH (0078-0502-61)

FDA lists these products with the same active ingredient.

0078-0501 — rivastigmine, 0078-0503 — rivastigmine, 0378-9070 — rivastigmine, 0378-9071 — rivastigmine, 0378-9072 — rivastigmine, 0781-7304 — rivastigmine, 0781-7309 — rivastigmine, 0781-7313 — rivastigmine, 16714-116 — Rivastigmine, 16714-117 — Rivastigmine, 51991-897 — Rivastigmine, 51991-898 — Rivastigmine, 51991-899 — Rivastigmine, 63629-2064 — Rivastigmine, 63629-2065 — Rivastigmine, 63629-2066 — Rivastigmine, 63629-8807 — Rivastigmine, 63629-8846 — Rivastigmine, 65162-749 — Rivastigmine, 65162-825 — Rivastigmine, +13 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.